The revenue stands at ₹521.17 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.98 per cent from ₹578.96 crore. This corresponds to a year-on-year *(YoY) decline of 2.24 per cent.
Operating Profit stands at ₹44.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 465.40 per cent from ₹7.92 crore. This corresponds to a year-on-year *(YoY) decline of 47.64 per cent.
PBDT stands at ₹324.68 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,472.30 per cent from ₹20.65 crore. This corresponds to a year-on-year *(YoY) growth of 251.42 per cent.
Profit Before Tax stands at ₹293.43 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2,811.92 per cent from ₹-10.82 crore. This corresponds to a year-on-year *(YoY) growth of 374.42 per cent.
Net Profit stands at ₹264.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2,322.79 per cent from ₹-11.89 crore. This represents a 356.85 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Unichem Labs. | 4.19% | 3.26% | 30.44% | 3.91% | -17.95% | -33.86% |
| Dishman Carbogen | 0.52% | 4.91% | 24.56% | -14.76% | -37.05% | -5.07% |
| Gufic BioScience | -0.85% | -2.65% | -1.57% | -3.62% | -12.94% | -20.85% |
| IOL Chemicals | -1.35% | 1.89% | 21.80% | 30.69% | -0.13% | 46.55% |
| Novartis India | -0.12% | 5.46% | 0.50% | 35.06% | 18.33% | 30.42% |
| Hikal | 0.29% | 0.26% | 18.14% | 1.42% | -22.37% | -52.36% |
| Morepen Labs. | -0.96% | -4.10% | 9.03% | 15.32% | -14.12% | -30.11% |
Non-Executive & Non-Independent Director : Pranay Godha
Managing Director : Pabitra Bhattacharya
Company Sec. & Compli. Officer : Pradeep Bhandari
Chairman (Non-Executive) : Prakash A Mody
Independent Director : Anand T Kusre
Independent Director : Arun Todarwal
Independent Director : Swati Patankar